Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
Young‐Suk Lim(Asan Medical Center), Dong Hyun Sinn(Samsung (South Korea)), Sang Hoon Ahn(Yonsei University), Jae‐Jun Shim(Kyung Hee University), Devin Razavi‐Shearer(University of Health Sciences Antigua), Homie Razavi(Center for Disease Analysis)
Cited by 33
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
|Clinics in Liver Disease|2008|314